← Back to All Filings

Medpace Officer Susan E. Burwig Proposes Sale of $10.87M in Common Stock

High SignificanceOctober 26, 2026 at 4:37:06 PM EDT

Medpace Holdings, Inc.

$MEDP144CIK: 0001668397

Subscribe to track MEDP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Form 144 Notice of Proposed Sale of Securities Company: Medpace Holdings, Inc. ($MEDP) Insider: Susan E. Burwig (Officer) Shares Offered: 16,060 Common Shares Market Value: $10,872,620.00 (~$677.00/share) Approx. Date of Sale: 10/26/2026 Broker: Fidelity Brokerage Services LLC

Comprehensive Analysis

Executive Summary

On October 26, 2026, Susan E. Burwig, an Officer of Medpace Holdings, Inc. ($MEDP), submitted a Form 144 filing declaring an intention to sell 16,060 shares of common stock through Fidelity Brokerage Services LLC. The aggregate market value of the proposed disposition is approximately $10,872,620.00, reflecting an implied price of $677.00 per share.

Origin of Securities

The shares proposed for sale were acquired through stock option exercises:

  • 10,000 shares acquired on August 26, 2025, via stock option exercise paid in cash.
  • 6,060 shares acquired on September 26, 2025, via stock option exercise paid in cash.

Trading History & Context

  • Over the preceding three-month period, Susan Burwig previously sold 7,500 shares on July 28, 2026, generating gross proceeds of $4,500,000.00.
  • Total units outstanding for Medpace Holdings, Inc. stood at 27,971,686, meaning this proposed transaction represents approximately 0.06% of the company's total shares outstanding.
  • Because this planned transaction exceeds $10 million in value and follows a prior multi-million-dollar sale in July 2026, it carries High trading significance for insider tracking.
Topics:#MEDP#Medpace#Form144#InsiderSelling#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.